SCHEMBL4425955

SCHEMBL4425955

[CH](CCN1CCOCC1)Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.58
SIGMAR1 Q99720 1/20 0.58
LTA4H P09960 1/20 0.49
KMT2A Q03164 4/20 0.47
ALDH1A1 P00352 3/20 0.47
MEN1 O00255 2/20 0.47
DRD1 P21728 1/20 0.47
DRD4 P21917 1/20 0.47
DRD5 P21918 1/20 0.47
USP2 O75604 1/20 0.47
HTT P42858 1/20 0.47
MAPT P10636 3/20 0.46
ATM Q13315 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8708628 0.83 POLB (0.53) POLBSIGMAR1LTA4HKMT2AALDH1A1
SCHEMBL6279414 0.77 ALDH1A1 (0.47) POLBSIGMAR1KMT2AALDH1A1MEN1
SCHEMBL78043 0.77 SIGMAR1 (0.79) POLBSIGMAR1KMT2AALDH1A1MEN1
SCHEMBL9539677 0.77 SIGMAR1 (0.79) POLBSIGMAR1KMT2AALDH1A1MEN1
SCHEMBL7408919 0.76 SIGMAR1 (0.53) POLBSIGMAR1KMT2AALDH1A1MEN1
SCHEMBL646005 0.75 KDM4E (0.50) POLBSIGMAR1ALDH1A1USP2
Ethylene SCHEMBL28207535 0.74 SIGMAR1 (0.74) POLBSIGMAR1KMT2AALDH1A1MEN1
SCHEMBL1711070 0.74 SIGMAR1 (1.00) POLBSIGMAR1LTA4HKMT2AHTT
SCHEMBL9779468 0.73 SIGMAR1 (0.71) POLBSIGMAR1KMT2AALDH1A1MEN1
SCHEMBL12605630 0.73 KCNH2 (0.69) POLBSIGMAR1KMT2AMEN1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682538-A4 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S BIO PTE LTD (SG) 2009-05-27 EP claimed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US claimed
EP-1682538-A1 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*Bio Pte Ltd (SG) 2006-07-26 EP claimed
WO-2005040161-A1 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*BIO PTE LTD (SG) 2005-05-06 WO claimed
EP-1682538-A4 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S BIO PTE LTD (SG) 2009-05-27 EP disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
EP-1682538-A1 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*Bio Pte Ltd (SG) 2006-07-26 EP disclosed
WO-2005040161-A1 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*BIO PTE LTD (SG) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications HDAC1, HDAC11, HDAC2 POLB 525/4885SIGMAR1 4425/4885LTA4H 848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.